ASMB - Assembly Biosciences Stock Trading

Assembly Biosciences (NASDAQ: ASMB) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Assembly released its 1Q21 results after the bell, and we had a chance to catch up with management this evening. The new information is incr...

SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today reported financial results and recent updates for the first quarter end...

Shares of Assembly Biosciences Inc. (NASDAQ:ASMB) traded today at $4.04, breaking its 52-week low. So far today approximately 2.4 million shares have been exchanged, as compared to an average 30-day volume of 910,000 shares. Assembly Biosciences Inc. (NASDAQ:ASMB) has potential upside of...